BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Mohammad Minakari, Mahsa Molaei, Hamid Mohaghegh Shalmani, Amir Houshang Mohammad Alizadeh, Amir Hosein Davarpanah Jazi, Nosratollah Naderi, Ahmad Shavakhi, Reza Mashayekhi, Mohammad Reza Zali. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factorsEuropean Journal of Gastroenterology & Hepatology 2009; 21(5): 512 doi: 10.1097/MEG.0b013e328326792e
2
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Non-invasive assessment of fatty liverOrvosi Hetilap 2015; 156(14): 543 doi: 10.1556/OH.2015.30123
3
Ilan S. Weisberg, Robert S. Brown, Samuel H. Sigal. Hepatitis B and End-Stage Liver DiseaseClinics in Liver Disease 2007; 11(4): 893 doi: 10.1016/j.cld.2007.08.009
4
Jun-ping Shi, Jian-gao Fan, Rui Wu, Xiao-qian Gao, Li Zhang, Hao Wang, Geoffrey C Farrell. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infectionJournal of Gastroenterology and Hepatology 2008; 23(9): 1419 doi: 10.1111/j.1440-1746.2008.05531.x
5
Yu-Qiang Mi, Qi-Yu Shi, Liang Xu, Rui-Fang Shi, Yong-Gang Liu, Ping Li, Feng Shen, Wei Lu, Jian-Gao Fan. Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis BDigestive Diseases and Sciences 2015; 60(1): 243 doi: 10.1007/s10620-014-3341-x
6
Manoj Kumar, Ajay Choudhury, Nitin Manglik, Syed Hissar, Archana Rastogi, Puja Sakhuja, Shiv K Sarin. Insulin Resistance in Chronic Hepatitis B Virus InfectionThe American Journal of Gastroenterology 2009; 104(1): 76 doi: 10.1038/ajg.2008.9
7
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangementAlimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
8
Reham M. Gameaa, Nehad Hawash, Rehab Badawi, Sherief Abd-Elsalam, Gamal K. Kasem, El-Sayed A. Wasfy. Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin ResistanceThe Open Biomarkers Journal 2019; 9(1): 70 doi: 10.2174/1875318301909010070
9
Rosa Zampino, Nicola Coppola, Grazia Cirillo, Adriana Boemio, Anna Grandone, Maria Stanzione, Nicolina Capoluongo, Aldo Marrone, Margherita Macera, Evangelista Sagnelli, Luigi Elio Adinolfi, Emanuele Miraglia del Giudice. Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis BDigestive Diseases and Sciences 2015; 60(10): 3005 doi: 10.1007/s10620-015-3716-7
10
E. Tsochatzis, G.V. Papatheodoridis, E.K. Manesis, N. Chrysanthos, G. Kafiri, A.J. Archimandritis. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: A comparative approach with genotype 1 chronic hepatitis CDigestive and Liver Disease 2007; 39(10): 936 doi: 10.1016/j.dld.2007.07.151
11
Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver DiseaseInternational Journal of Environmental Research and Public Health 2019; 16(15): 2755 doi: 10.3390/ijerph16152755
12
Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Winnie Chiu-Wing Chu, Angel Mei-Ling Chim, Arlinking Ong, David Ka-Wai Yeung, Karen Kar-Lum Yiu, Shirley Ho-Ting Chu, Hoi-Yun Chan, Jean Woo, Francis Ka-Leung Chan, Henry Lik-Yuen Chan. Hepatitis B virus infection and fatty liver in the general populationJournal of Hepatology 2012; 56(3): 533 doi: 10.1016/j.jhep.2011.09.013
13
Mauro Viganò, Luca Valenti, Pietro Lampertico, Floriana Facchetti, Benedetta Maria Motta, Roberta D'Ambrosio, Solange Romagnoli, Paola Dongiovanni, Benedetta Donati, Silvia Fargion, Massimo Colombo. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis BHepatology 2013; 58(4): 1245 doi: 10.1002/hep.26445
14
Angélica Luciana Nau, Júlia Cristina Soares, Maria Beatriz Cacese Shiozawa, Esther Buzaglo Dantas-Corrêa, Leonardo de Lucca Schiavon, Janaína Luz Narciso-Schiavon. Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriersRevista da Sociedade Brasileira de Medicina Tropical 2014; 47(2): 158 doi: 10.1590/0037-8682-0009-2014
15
Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B diseaseHuman Vaccines & Immunotherapeutics 2017; 13(11): 2695 doi: 10.1080/21645515.2017.1353850
16
Chia-Chi Wang, Tai-Chung Tseng, Jia-Horng Kao. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?Journal of Gastroenterology and Hepatology 2015; 30(1): 14 doi: 10.1111/jgh.12700
17
Jing Liang, Wenjuan Cai, Tao Han, Li Jing, Zhe Ma, Yingtang Gao. The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver diseaseMedicine 2016; 95(52): e5763 doi: 10.1097/MD.0000000000005763
18
Mehmet Cindoruk, Tarkan Karakan, Selahattin Unal. Hepatic Steatosis has no Impact on the Outcome of Treatment in Patients With Chronic Hepatitis B InfectionJournal of Clinical Gastroenterology 2007; 41(5): 513 doi: 10.1097/01.mcg.0000225586.78330.60
19
Xudong Liu, Zhen Shen, Hongxing Zhang, Jian Liang, Hai Lin. Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver DiseaseJournal of Interferon & Cytokine Research 2016; 36(6): 367 doi: 10.1089/jir.2015.0129
20
Dandan Peng, Ying Han, Huiguo Ding, Lai Wei. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factorsJournal of Gastroenterology and Hepatology 2008; 23(7pt1): 1082 doi: 10.1111/j.1440-1746.2008.05478.x
21
Ya-Yu Wang, Shih-Yi Lin, Wayne Huey-Herng Sheu, Pi-Hwa Liu, Kwong-Chung Tung. Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infectionMetabolism 2010; 59(4): 486 doi: 10.1016/j.metabol.2009.07.038
22
F. Negro. Liver under Constant Attack — From Fat to Viruses2009; : 41 doi: 10.1007/978-90-481-2759-7_6
23
Arezoo Estakhri, Ali Akbari Sari, Sahar Naz Nedjat, Marym Rohban, Naser Rakhshani, Seyed Mohammad Tavangar, Reza Malekzadeh, Ghodrat Montazeri. The effect of NAFLD (non-alcoholic fatty liver disease) on long-term outcome of chronic hepatitis B in Iranian patientsOpen Journal of Gastroenterology 2012; 2(01): 18 doi: 10.4236/ojgas.2012.21004
24
Chu-wen Lin, Xiao-li Huang, Hai-lin Liu, Yan Wang. Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical ImpactDigestive Diseases and Sciences 2015; 60(12): 3513 doi: 10.1007/s10620-015-3772-z
25
Konstantinos C. Thomopoulos, Vassiliki Arvaniti, Athanasios C. Tsamantas, Dimitra Dimitropoulou, Charalambos A. Gogos, Dimitrios Siagris, George J. Theocharis, Chryssoula Labropoulou-Karatza. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosisEuropean Journal of Gastroenterology & Hepatology 2006; 18(3): 233 doi: 10.1097/00042737-200603000-00002
26
Zhan-Ming Li, Chao-Yue Kong, Shi-Long Zhang, Bing Han, Zheng-Yan Zhang, Li-Shun Wang. Alcohol and HBV synergistically promote hepatic steatosisAnnals of Hepatology 2019; 18(6): 913 doi: 10.1016/j.aohep.2019.04.013
27
Erin M. Kelly, Vickie A. Feldstein, Dustin Etheridge, Rebecca Hudock, Marion G. Peters. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis BJournal of Ultrasound in Medicine 2017; 36(5): 925 doi: 10.7863/ultra.16.04076
28
Mohsen Razavizade, Raika Jamali, Abbas Arj, Hamidreza Talari. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver diseaseHepatobiliary & Pancreatic Diseases International 2012; 11(5): 513 doi: 10.1016/S1499-3872(12)60216-1
29
Daisuke Yamane, David R. McGivern, Takahiro Masaki, Stanley M. Lemon. Hepatitis C Virus: From Molecular Virology to Antiviral TherapyCurrent Topics in Microbiology and Immunology 2013; 369: 263 doi: 10.1007/978-3-642-27340-7_11
30
Suraphan Panyod, Lee-Yan Sheen. Beneficial effects of Chinese herbs in the treatment of fatty liver diseasesJournal of Traditional and Complementary Medicine 2020; 10(3): 260 doi: 10.1016/j.jtcme.2020.02.008
31
Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, Mengting Li, Yuanwen Chen, Jun Li, Jiangao Fan. Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?Liver International 2020; 40(3): 496 doi: 10.1111/liv.14369
32
Li-chen Wu, Ja-an Annie Ho. Spirulina in Human Nutrition and Health2007; : 119 doi: 10.1201/9781420052572.ch6
33
KyeongJin Kim, Kook Hwan Kim, Hyeong Hoe Kim, JaeHun Cheong. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRαBiochemical Journal 2008; 416(2): 219 doi: 10.1042/BJ20081336
34
Wei-Chieh Hung, Jin-Shang Wu, Yi-Ching Yang, Zih-Jie Sun, Feng-Hwa Lu, Chih-Jen Chang. Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitisEuropean Journal of Clinical Investigation 2014; 44(12): 1143 doi: 10.1111/eci.12348
35
Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2020;  doi: 10.1111/jgh.15026
36
Jin Tong, Jinjun Guo, Jun Hu, Sihui Hou, Yu Zhang, Qingling Li. Correlation Between Patatin-Like Phospholipase Domain-Containing Protein 3 Gene Polymorphisms and Liver Cirrhosis in a Chinese Han Population With Chronic Hepatitis BHepatitis Monthly 2014; 14(8) doi: 10.5812/hepatmon.18943
37
Salvatore Petta, Calogero Cammà, Vito Di Marco, Fabio Salvatore Macaluso, Marcello Maida, Giuseppe Pizzolanti, Beatrice Belmonte, Daniela Cabibi, Rosa Di Stefano, Donatella Ferraro, Carla Guarnotta, Giovanna Venezia, Antonio Craxì. Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infectionLiver International 2011; 31(4): 507 doi: 10.1111/j.1478-3231.2011.02453.x
38
Ghodsiyeh Azarkar, Tayebeh Zeinali, Gholamreza Sharifzadeh, Farshid Abedi, Morteza Hajihosseini, Masood Ziaee. Prevalence of Non-Alcoholic Fatty Liver and its Related Factors in Birjand, During Year 2015Modern Care Journal 2016; 13(4) doi: 10.5812/modernc.58829
39
Anthony W.H. Chan, Grace L.H. Wong, Vincent W.S. Wong. Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B InfectionCurrent Hepatology Reports 2017; 16(2): 97 doi: 10.1007/s11901-017-0340-3
40
Zhengtao Liu, Yanling Hu, Xiaobo Yang, Aihua Tan, Yong Gao, Xue Qin, Yu Liang, Zengnan Mo, Tao Peng. Combinative analysis of factors influence serum alanine aminotransferase activity in adult male population from southern ChinaClinical Biochemistry 2012; 45(18): 1683 doi: 10.1016/j.clinbiochem.2012.08.022
41
Sara Saki, Nader Saki, Hossein Poustchi, Reza Malekzadeh. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular EventsMiddle East Journal of Digestive Diseases 2020; 12(2): 65 doi: 10.34172/mejdd.2020.166
42
Vahdat Poortahmasebi, Seyed Moayed Alavian, Hossein Keyvani, Mehdi Norouzi, Mahmood Mahmoodi, Seyed Mohammad Jazayeri. Hepatic Steatosis: Prevalence and Host/Viral Risk Factors in Iranian Patients with Chronic Hepatitis B InfectionAsian Pacific Journal of Cancer Prevention 2014; 15(9): 3879 doi: 10.7314/APJCP.2014.15.9.3879
43
G. Forlani, P. Di Bonito, E. Mannucci, B. Capaldo, S. Genovese, M. Orrasch, L. Scaldaferri, P. Di Bartolo, P. Melandri, A. Dei Cas, I. Zavaroni, G. Marchesini. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndromeJournal of Endocrinological Investigation 2008; 31(2): 146 doi: 10.1007/BF03345581
44
Jian-Gao Fan, Shivakumar Chitturi. Hepatitis B and fatty liver: Causal or coincidental?Journal of Gastroenterology and Hepatology 2008; 23(5): 679 doi: 10.1111/j.1440-1746.2008.05361.x
45
Xi Jin, Yi-peng Chen, Yi-da Yang, You-ming Li, Lin Zheng, Chuan-qing Xu, Ravi Jhaveri. Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis BPLoS ONE 2012; 7(3): e34198 doi: 10.1371/journal.pone.0034198
46
Huiqing Liang, Yaoyu Liu, Xiaoqian Jiang, Xiaoting Zheng, Jinmo Tang, Jiaen Yang, Hongli Zhuang, Penghua Lai, Li Peng, Zhenying Guo, Shanshan Cai, Dan Luo, Lingxia Xu, Qianguo Mao, Shaodong Chen. Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated MechanismGastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/1794769
47
Zehra Karacaer, Gokcan Okur, Hakan Cermik, Demet Altun. Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?Postgraduate Medicine 2016; 128(7): 697 doi: 10.1080/00325481.2016.1221733
48
Raphael B. Merriman. Nonalcoholic fatty liver disease and HIV infectionCurrent HIV/AIDS Reports 2006; 3(3): 113 doi: 10.1007/BF02696654
49
Mostafa Mohamed El-Sheekh, Saied Mohamed Hamad, Mahmoud Gomaa. Protective effects of Spirulina on the liver function and hyperlipidemia of rats and humanBrazilian Archives of Biology and Technology 2014; 57(1): 77 doi: 10.1590/S1516-89132014000100012
50
C-M Chu, D-Y Lin, Y-F Liaw. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?International Journal of Obesity 2007; 31(5): 871 doi: 10.1038/sj.ijo.0803479
51
Silvia Bondini, Jillian Kallman, Angela Wheeler, Shivaani Prakash, Terry Gramlich, Daniel M. Jondle, Zobair M. Younossi. Impact of non-alcoholic fatty liver disease on chronic hepatitis BLiver International 2007; 27(5): 607 doi: 10.1111/j.1478-3231.2007.01482.x
52
Joseph K. Lim, Mindie H. Nguyen. The Role of Hepatic Steatosis in Chronic Hepatitis B InfectionCurrent Hepatitis Reports 2011; 10(2): 134 doi: 10.1007/s11901-011-0090-6
53
Saman Ghalamkari, Heidar Sharafi, Seyed Moayed Alavian. Association ofPNPLA3rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: Systematic review with meta-analysisThe Journal of Gene Medicine 2018; 20(1): e3001 doi: 10.1002/jgm.3001
54
Raluca Pais, Elena Rusu, Vlad Ratziu. The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis B and Drug-Induced Liver DiseaseClinics in Liver Disease 2014; 18(1): 165 doi: 10.1016/j.cld.2013.09.015